Tag Archive: Curaleaf
Industry Players Respond To DEA’s Rescheduling Announcement
Last week, the Drug Enforcement Agency announced a rescheduling for cannabis, moving the drug from Schedule I to Schedule III. Continue reading →
Posted in News on May 7, 2024Curaleaf Up 6% In 2023, With Sales Reaching $1.35 Billion
Multistate player Curaleaf reached a new sales record last year, rising 6% to $1.35 billion after a strong fourth quarter. Continue reading →
Posted in News on March 12, 2024Cannabis Briefs for February 13, 2024
•Massachusetts cannabis retailers had total sales of $1.56 billion in 2023, a new record, according to the state’s Cannabis Control Commission, up by $78 million from the prior year, a 5% increase. Continue reading →
Posted in News on February 13, 2024Multi-State Players Curaleaf, PharmaCann Target Growth In New York
After a slow launch, hamstrung by licensing delays and lawsuits, New York’s adult-use cannabis market is seeing investment from multi-state operators, with billion-dollar player Curaleaf as well as PharmaCann both entering the adult-use market and telling SNDC they see opportunity ahead. Continue reading →
Posted in News on January 30, 2024Cannabis Briefs for January 23, 2024
•Curaleaf is entering the New York retail market, receiving its first license to open a retail shop in Newburgh, about 70 miles north of New York City. Continue reading →
Posted in News on January 23, 2024New York Aims To Have 37 Dispensaries Open By Year-End
While New York’s cannabis market has been plagued by a slow retail rollout, the Empire State is now looking to ramp up licensing and open as many as a dozen new stores by the end of the year, reaching a total of 37 dispensaries statewide. Continue reading →
Posted in News on December 19, 2023
